Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Moran

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Cancer Research|December 18, 2015
Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene MutationsErick Riquelme, Carmen Behrens, Heather Y Lin, et al.
The Journal of Urology|July 13, 2004
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke, Colin P Dinney, Neil A Abrahams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerLudmila Prudkin, Carmen Behrens, Diane D Liu, et al.
Advances in Radiation Oncology|June 16, 2018
Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealantPatricia M de Groot, Girish S Shroff, Judy Ahrar, et al.
Scientific Reports|May 5, 2019
Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort StudyXin Luo, Shen Yin, Lin Yang, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Nature Communications|May 15, 2023
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerEdwin Roger Parra, Jiexin Zhang, Mei Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
The Annals of Thoracic Surgery|July 9, 2010
Non-small cell lung cancer resection in lymphoma patientsMin P Kim, Arlene M Correa, Stephen G Swisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosisXiming Tang, Humam Kadara, Carmen Behrens, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Cancer Research|December 18, 2015
Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene MutationsErick Riquelme, Carmen Behrens, Heather Y Lin, et al.
The Journal of Urology|July 13, 2004
Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experienceArlene O Siefker-Radtke, Colin P Dinney, Neil A Abrahams, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancerLudmila Prudkin, Carmen Behrens, Diane D Liu, et al.
Advances in Radiation Oncology|June 16, 2018
Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealantPatricia M de Groot, Girish S Shroff, Judy Ahrar, et al.
Scientific Reports|May 5, 2019
Development and Validation of a Pathology Image Analysis-based Predictive Model for Lung Adenocarcinoma Prognosis - A Multi-cohort StudyXin Luo, Shen Yin, Lin Yang, et al.
Annals of Diagnostic Pathology|April 22, 2014
Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesotheliomaAnne S Tsao, Nusrat Harun, Junya Fujimoto, et al.
Nature Communications|May 15, 2023
Immune cellular patterns of distribution affect outcomes of patients with non-small cell lung cancerEdwin Roger Parra, Jiexin Zhang, Mei Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutationMaria G Raso, Carmen Behrens, Matthew H Herynk, et al.
The Annals of Thoracic Surgery|July 9, 2010
Non-small cell lung cancer resection in lymphoma patientsMin P Kim, Arlene M Correa, Stephen G Swisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosisXiming Tang, Humam Kadara, Carmen Behrens, et al.
Pageof 8